Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical Chemistry and …, 2006 - degruyter.com
Background: Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …
被引用次数：64 相关文章

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical chemistry and …, 2006 - sonar.ch
METHODS We enrolled 117 patients with histologically proven DTC treated by total
thyroidectomy and radioiodine. Inclusion criteria were: complete tumour excision, no …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - CLINICAL …, 2006 - iris.hunimed.eu
BACKGROUND: Circulating human thyroglobulin (TG) measurement has a pivotal role in
the management of patients affected by differentiated thyroid cancer (DTC). Undetectable …
[PDF] researchgate.net

[PDF][PDF] Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin …

L Giovanella, L Ceriani, A Ghelfo, F Keller, A Sacchi… - researchgate.net
Background: Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo… - Clinical Chemistry & …, 2006 - search.ebscohost.com
Background: Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical Chemistry and …, 2006 - degruyter.com
Background: Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical Chemistry …, 2006 - europepmc.org
Background Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical chemistry and …, 2006 - folia.unifr.ch
METHODS We enrolled 117 patients with histologically proven DTC treated by total
thyroidectomy and radioiodine. Inclusion criteria were: complete tumour excision, no …

[引用][C] Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin …

L GIOVANELLA, L CERIANI, A GHELFO… - Clinical chemistry …, 2006 - pascal-francis.inist.fr
Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer
management : comparison with recombinant human thyrotropin-stimulated assay and …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo… - Clinical chemistry …, 2006 - pubmed.ncbi.nlm.nih.gov
Background Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …